title: Effect of an aldose reductase inhibiting agent on limited joint mobility in IDDM.
authors.forename: A L
authors.initials: AL
authors.lastname: Rosenbloom
authors.forename: M
authors.initials: M
authors.lastname: Buithieu
authors.forename: K A
authors.initials: KA
authors.lastname: Jelliffe
authors.forename: R D
authors.initials: RD
authors.lastname: Aitchison
authors.forename: J A
authors.initials: JA
authors.lastname: Truglia
mesh_terms: D000328:Adult; D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D001794:Blood Pressure; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000503:physiopathology; D004311:Double-Blind Method; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006339:Heart Rate; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008297:Male; D009068:Movement; D009460:Neurologic Examination; D010793:Phthalazines / Q000627:therapeutic use*
chemical_list: D000449:Aldehyde Reductase; D006442:Glycated Hemoglobin; D010793:Phthalazines; C042829:ponalrestat